학술논문
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
Document Type
Article
Author
Nicolle, Rémy; Bachet, Jean-Baptiste; Harlé, Alexandre; Iovanna, Juan; Hammel, Pascal; Rebours, Vinciane; Turpin, Anthony; Ben Abdelghani, Meher; Wei, Alice; Mitry, Emmanuel; Lopez, Anthony; Biagi, James; François, Eric; Artru, Pascal; Lambert, Aurélien; Renouf, Daniel J.; Monard, Laure; Mauduit, Marjorie; Dusetti, Nelson; Conroy, Thierry
Source
Journal of Clinical Oncology; 3/20/2024, Vol. 42 Issue 9, p1067-1076, 13p
Subject
Language
ISSN
0732183X